Schedule 13G ownership disclosure

TRAVERE THERAPEUTICS INC

Security class unavailable · CUSIP: 89422G107

Event date: 2023-05-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-060912
Form type
SC 13G/A
Filer
RA CAPITAL MANAGEMENT, L.P.
CIK
CIK 1346824
Filed
May 15, 2023
Reporting period
May 15, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub